Neurocognitive development of children born small for gestational age (SGA). An update

The aim of the present study is to confirm that being born SGA is a serious risk for a negative neurocognitive development. 233 cases have been controlled yearly and longitudinally by the same investigator, some of them 11 times, showing 25,8 % an IQ less than 2 SD, being less affected the catch-up...

Full description

Saved in:
Bibliographic Details
Published inPediatric endocrinology reviews : PER Vol. 9; no. 4; p. 716
Main Authors Puga, Beatriz, Gil, Paloma, de Arriba, Antonio, Labarta, José Ignacio, Romo, Agustín, Mayayo, Esteban, Ferrández Longás, Angel
Format Journal Article
LanguageEnglish
Published Israel 01.08.2012
Subjects
Adolescent
Brain - growth & development
Child
Child, Preschool
Cognition - physiology
Female
Follow-Up Studies
Growth Disorders - drug therapy
Growth Disorders - epidemiology
Human Growth Hormone - therapeutic use
Humans
Infant
Infant, Newborn
Infant, Small for Gestational Age - growth & development
Longitudinal Studies
Male
Risk Factors
Online AccessGet more information

Cover

More Information
Summary:The aim of the present study is to confirm that being born SGA is a serious risk for a negative neurocognitive development. 233 cases have been controlled yearly and longitudinally by the same investigator, some of them 11 times, showing 25,8 % an IQ less than 2 SD, being less affected the catch-up + group (15 %), compared to the catch-up - group (31,4 %). The GH therapy (n 64) started before the age of 6 (n 38) or after 6 (n 26), doesn't improve the negative outcome.
ISSN:1565-4753